April 2026 Category 2 Update On April 15, 2026, the FDA confirmed removal of injectable GHK-Cu from Category 2 because the original nominations were withdrawn
It received the blessing of the players association, whose president, Chris Paul, said: The good thing for our league is that were always trying things, adding things, to see what our fans like. Well, in the flurry of a finish, these were the scenes: Giannis Antetokounmpo blocking shots by LeBron and Davis LeBron returning favor by forcing Giannis to lose the ball out of bounds and a bucket exchange down the stretch by Leonard and Joel Embiid
Repeat-dose toxicity: Subcutaneous injections of TA-1 in mice, rats, and marmosets over 13 weeks (up to 6mg/kg per day) and 26 weeks (up to 1mg/kg per day) led to no drug-related adverse effects
The study also highlighted AOD9604s influence on fat metabolism and energy expenditure, and its interaction with 3-adrenergic pathways [2]
06 Need guidance
These projects are more vulnerable to documentation drift because small inconsistencies in preparation inputs can propagate across measurement layers and create avoidable uncertainty